These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 17690249)
1. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249 [TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells. Gudas JM; Klein RC; Oka M; Cowan KH Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978 [TBL] [Abstract][Full Text] [Related]
3. CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression. Mitra P; Yang RM; Sutton J; Ramsay RG; Gonda TJ Oncotarget; 2016 Feb; 7(8):9069-83. PubMed ID: 26812885 [TBL] [Abstract][Full Text] [Related]
4. Identification and regulation of c-Myb target genes in MCF-7 cells. Quintana AM; Liu F; O'Rourke JP; Ness SA BMC Cancer; 2011 Jan; 11():30. PubMed ID: 21261996 [TBL] [Abstract][Full Text] [Related]
5. [The expression of c-myb is strongly associated with the presence of estrogen and progesterone receptors in breast cancer]. Guerin M; Barrois M; Riou G C R Acad Sci III; 1988; 307(20):855-61. PubMed ID: 2907731 [TBL] [Abstract][Full Text] [Related]
6. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ; Jordan VC Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307 [TBL] [Abstract][Full Text] [Related]
7. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells. Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773 [TBL] [Abstract][Full Text] [Related]
8. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Stender JD; Frasor J; Komm B; Chang KC; Kraus WL; Katzenellenbogen BS Mol Endocrinol; 2007 Sep; 21(9):2112-23. PubMed ID: 17550982 [TBL] [Abstract][Full Text] [Related]
9. Estrogen and MYB in breast cancer: potential for new therapies. Gonda TJ; Leo P; Ramsay RG Expert Opin Biol Ther; 2008 Jun; 8(6):713-7. PubMed ID: 18476782 [TBL] [Abstract][Full Text] [Related]
10. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269 [TBL] [Abstract][Full Text] [Related]
11. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-α recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB gene. Mitra P; Pereira LA; Drabsch Y; Ramsay RG; Gonda TJ Nucleic Acids Res; 2012 Jul; 40(13):5988-6000. PubMed ID: 22492511 [TBL] [Abstract][Full Text] [Related]
13. Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells. Coutts AS; Leygue E; Murphy LC J Mol Endocrinol; 1999 Dec; 23(3):325-36. PubMed ID: 10601978 [TBL] [Abstract][Full Text] [Related]
14. MYB suppresses differentiation and apoptosis of human breast cancer cells. Drabsch Y; Robert RG; Gonda TJ Breast Cancer Res; 2010; 12(4):R55. PubMed ID: 20659323 [TBL] [Abstract][Full Text] [Related]
15. Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Jin W; Liu Y; Chen L; Zhu H; Di GH; Ling H; Wu J; Shao ZM Breast Cancer Res Treat; 2011 Feb; 125(3):699-713. PubMed ID: 20364308 [TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Jeng MH; Shupnik MA; Bender TP; Westin EH; Bandyopadhyay D; Kumar R; Masamura S; Santen RJ Endocrinology; 1998 Oct; 139(10):4164-74. PubMed ID: 9751496 [TBL] [Abstract][Full Text] [Related]
17. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs. Martini PG; Katzenellenbogen BS Endocrinology; 2001 Aug; 142(8):3493-501. PubMed ID: 11459795 [TBL] [Abstract][Full Text] [Related]
18. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines. Thompson MA; Flegg R; Westin EH; Ramsay RG Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073 [TBL] [Abstract][Full Text] [Related]
20. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway. Ariazi EA; Kraus RJ; Farrell ML; Jordan VC; Mertz JE Mol Cancer Res; 2007 Jan; 5(1):71-85. PubMed ID: 17259347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]